FindTrial
Sign In

Prognostic determinants in vulvar cancer: A national multicenter evaluation of therapeutic approaches and clinicopathological variables

Prognostic determinants in vulvar cancer: A national multicenter evaluation of therapeutic approaches and clinicopathological variables

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110559
Enrollment
Unknown
Registered
2025-10-15
Start date
2024-01-08
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vulvar cancer

Interventions

Surgery group:Surgery
Non-surgery group:Non-surgery

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. the initial diagnosis of the patients in each centre was made between 2000.01.01 and 2023.10.31; 2. The pathological diagnosis was VC; 3. basic clinical information and survival follow-up data were complete

Exclusion criteria

Exclusion criteria: 1. Patients with a combination of other malignant tumours; 2. Incomplete basic clinical information and follow-up data.

Design outcomes

Primary

MeasureTime frame
cancer-specific survival;Recurrence and mortality outcomes in patients with VC;—

Countries

China

Contacts

Public ContactSong Kun

Qilu Hospital of Shandong University

songkun2001226@sdu.edu.cn+86 531 8692 7544

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026